Fluoxetine is a potent inhibitor of coxsackievirus replication.
about
Screening of a Library of FDA-Approved Drugs Identifies Several Enterovirus Replication Inhibitors That Target Viral Protein 2CHuman induced pluripotent stem cell-derived cardiomyocytes as an in vitro model for coxsackievirus B3-induced myocarditis and antiviral drug screening platform.Identification of luteolin as enterovirus 71 and coxsackievirus A16 inhibitors through reporter viruses and cell viability-based screeningMyocarditis, disseminated infection, and early viral persistence following experimental coxsackievirus B infection of cynomolgus monkeysDiscovery of Structurally Diverse Small-Molecule Compounds with Broad Antiviral Activity against Enteroviruses.Recent progress in understanding coxsackievirus replication, dissemination, and pathogenesis.N-Desmethylclozapine, Fluoxetine, and Salmeterol Inhibit Postentry Stages of the Dengue Virus Life Cycle.Development of a fluorescence resonance energy transfer-based intracellular assay to identify novel enterovirus 71 antivirals.Enteroviruses in the early 21st century: new manifestations and challengesSelective serotonin reuptake inhibitor fluoxetine inhibits replication of human enteroviruses B and D by targeting viral protein 2C.Rationale for the evaluation of fluoxetine in the treatment of enterovirus D68-associated acute flaccid myelitis.Crystal structure of a soluble fragment of poliovirus 2CATPase
P2860
Q28833169-BD2CD6F6-CFE9-4AD3-A2DA-B507E88D94EBQ30586653-C5AF0AB0-7BB0-4805-B0EE-D9DBB3D40DD0Q33963444-D9C69203-B7F2-4D4C-8007-334762EDF58AQ34990152-8C529DFF-28FE-4B68-90D7-A31CD5D7A1F6Q35880074-0CFE5E34-1CE0-4D71-BA11-F57769AE61DEQ36052773-5C02DC40-0818-4BAD-BABC-E26F700E42D6Q36116232-FCB7E1F6-86A6-4025-8A2C-2F25C048C421Q36200660-BF22C467-3078-4F05-8999-5052B67CD854Q36571245-F98ACA71-092B-4E70-B758-CA4245314C57Q36757571-DA8FD967-A7A5-4C35-864C-38C587C37F10Q37378440-85EDB180-33BC-4DDA-920B-6DF2DCCC22EBQ58715717-49098DC5-8757-430C-89D6-47BF3F06296F
P2860
Fluoxetine is a potent inhibitor of coxsackievirus replication.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Fluoxetine is a potent inhibitor of coxsackievirus replication.
@ast
Fluoxetine is a potent inhibitor of coxsackievirus replication.
@en
Fluoxetine is a potent inhibitor of coxsackievirus replication.
@nl
type
label
Fluoxetine is a potent inhibitor of coxsackievirus replication.
@ast
Fluoxetine is a potent inhibitor of coxsackievirus replication.
@en
Fluoxetine is a potent inhibitor of coxsackievirus replication.
@nl
prefLabel
Fluoxetine is a potent inhibitor of coxsackievirus replication.
@ast
Fluoxetine is a potent inhibitor of coxsackievirus replication.
@en
Fluoxetine is a potent inhibitor of coxsackievirus replication.
@nl
P2093
P2860
P356
P1476
Fluoxetine is a potent inhibitor of coxsackievirus replication.
@en
P2093
Kevin K Quinn
Paige Cooper
Paul Krogstad
Robert Damoiseaux
P2860
P304
P356
10.1128/AAC.00983-12
P407
P577
2012-07-02T00:00:00Z